Skip to content

Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology

Development of a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06955468
Acronym
Prime GOC
Enrollment
40
Registered
2025-05-02
Start date
2025-07-21
Completion date
2026-03-01
Last updated
2026-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Cancers, Lung Cancers

Keywords

Communication

Brief summary

This pilot study will evaluate whether an intervention aimed at hospitalized patients with advanced lung and gastrointestinal cancers can help facilitate goals-of-care (GOC) communication with their oncologists after discharge. While GOC communication is a recommended component of routine oncology care, many patients with solid cancers do not have the opportunity to talk with their oncologist about their goals and end-of-life preferences. Prior research has shown that a systematic method of prompting GOC communication with at-risk patients would address a key barrier to timely GOC communication and ensure that patients receive care that is in line with their personal preferences. This trial will enroll 80 participants, who will be randomized 1:1 to either an intervention or a control group. Participants in the intervention group will complete a short survey regarding their goals, preferences, and disease understanding. Survey responses will be shared with each participant's outpatient oncology team. Oncologists will subsequently receive a nudge in the electronic medical record reminding them of key survey responses and encouraging them to discuss them at the patient's first clinic visit after hospital discharge. The primary feasibility outcome is intervention completion rate and the primary clinical outcome is GOC documentation within 30 days of discharge in the intervention group compared to the control group.

Interventions

BEHAVIORALPriming Survey

13-item priming survey assessing patients' goals, treatment preferences, and disease understanding.

Sponsors

Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER
Conquer Cancer Foundation
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Unplanned admission to the HUP Solid Oncology service; 2. Underlying diagnosis of advanced lung or GI cancer, defined as metastatic or locally advanced disease; 3. Anticipated discharge within the next 72h; and 4. Primary oncologist is based at HUP; or 5. Family member/caregiver of a patient meeting the above 4 criteria.

Exclusion criteria

1\. Unable to complete survey in English.

Design outcomes

Primary

MeasureTime frameDescription
Intervention Completion RateFrom enrollment to 30 days after hospital dischargeThe primary feasibility outcome is intervention completion rate, defined as successful completion of the survey, response sharing, and electronic medical record nudge for all participants assigned to the intervention arm.
GOC DocumentationFrom enrollment to 30 days after hospital dischargeThe presence of outpatient goals-of-care documentation in the electronic medical record within 30 days of hospital discharge as determined by manual review.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026